IL110117A0 - Pharmaceutical compositions comprising vitamin-d analogs - Google Patents
Pharmaceutical compositions comprising vitamin-d analogsInfo
- Publication number
- IL110117A0 IL110117A0 IL11011794A IL11011794A IL110117A0 IL 110117 A0 IL110117 A0 IL 110117A0 IL 11011794 A IL11011794 A IL 11011794A IL 11011794 A IL11011794 A IL 11011794A IL 110117 A0 IL110117 A0 IL 110117A0
- Authority
- IL
- Israel
- Prior art keywords
- analogs
- vitamin
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11011794A IL110117A0 (en) | 1994-06-24 | 1994-06-24 | Pharmaceutical compositions comprising vitamin-d analogs |
PCT/US1995/008005 WO1996000074A1 (en) | 1994-06-24 | 1995-06-22 | Pharmaceutical compositions comprising vitamin-d analogs |
AU29980/95A AU2998095A (en) | 1994-06-24 | 1995-06-22 | Pharmaceutical compositions comprising vitamin-d analogs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11011794A IL110117A0 (en) | 1994-06-24 | 1994-06-24 | Pharmaceutical compositions comprising vitamin-d analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
IL110117A0 true IL110117A0 (en) | 1994-10-07 |
Family
ID=11066274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11011794A IL110117A0 (en) | 1994-06-24 | 1994-06-24 | Pharmaceutical compositions comprising vitamin-d analogs |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2998095A (en) |
IL (1) | IL110117A0 (en) |
WO (1) | WO1996000074A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5795882A (en) * | 1992-06-22 | 1998-08-18 | Bone Care International, Inc. | Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations |
FR2759586B1 (en) * | 1997-02-20 | 2000-01-14 | Paul Trouillas | ANTI-CANCER TYPE DRUG COMPRISING AT LEAST AS THE ACTIVE INGREDIENT OF 1-ALPHA HYDROXYCALCIFEROL OR ALFACALCIDOL |
ES2368824T3 (en) | 1998-03-27 | 2011-11-22 | Oregon Health & Science University | VITAMIN D AND ITS ANALOGS IN THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATIVE DISORDERS. |
KR100438254B1 (en) * | 2001-03-29 | 2004-07-02 | 아이큐어 주식회사 | Matrix form of preparation for transdermal administration of vitamin d analog |
AU2003252332A1 (en) * | 2002-08-01 | 2004-02-23 | Chugai Seiyaku Kabushiki Kaisha | Antipsoriatic agent |
WO2004028515A1 (en) * | 2002-09-26 | 2004-04-08 | Young-Kweon Choi | Matrix type patch for transdermal administration of vitamin d analog and the use thereof |
ZA200710371B (en) * | 2005-05-10 | 2009-07-29 | Dermipsor Ltd | Compositions and methods for treating hyperproliferative epidermal diseases |
ES2593047T3 (en) | 2006-02-03 | 2016-12-05 | Opko Renal, Llc | Treatment of vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 |
ES2670029T3 (en) | 2006-06-21 | 2018-05-29 | Opko Ireland Global Holdings, Ltd. | Therapy using vitamin D replenishment agent and vitamin D hormone replacement agent |
US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
EP2148685A4 (en) | 2007-04-25 | 2010-07-28 | Cytochroma Inc | Methods and compounds for vitamin d therapy |
EP2762132A1 (en) | 2007-04-25 | 2014-08-06 | Cytochroma Inc. | Controlled Release 25-Hydroxyvitamin D |
US20100144684A1 (en) | 2007-04-25 | 2010-06-10 | Proventiv Therapeutics, Inc. | Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease |
DK2148684T3 (en) | 2007-04-25 | 2013-04-22 | Cytochroma Inc | Method of treating vitamin D insufficiency and deficiency |
CN106853250A (en) | 2008-04-02 | 2017-06-16 | 赛特克罗公司 | Method, composition, purposes and kit for vitamin D deficiency and associated disorders |
PT2552484T (en) | 2010-03-29 | 2020-04-03 | Opko Ireland Global Holdings Ltd | Methods and compositions for reducing parathyroid levels |
JP6105494B2 (en) | 2011-03-14 | 2017-03-29 | ドラッグ デリバリー ソリューションズ リミテッド | Ophthalmic composition |
KR101847947B1 (en) * | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | Stabilized modified release vitamin d formulation |
US20160008377A1 (en) * | 2014-07-12 | 2016-01-14 | Aphios Corporation | Formulations and compositions of vitamin d analogs for treating and preventing cancer and other diseases |
SG10201911274TA (en) | 2014-08-07 | 2020-02-27 | Opko Ireland Global Holdings Ltd | Adjunctive therapy with 25-hydroxyvitamin d |
TWI747893B (en) | 2016-03-28 | 2021-12-01 | 愛爾蘭商歐科愛爾蘭全球控股股份有限公司 | Methods of vitamin d treatment |
EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990009179A1 (en) * | 1989-02-16 | 1990-08-23 | University Of Georgia Research Foundation, Inc. | Treatment of tibial dyschondroplasia |
KR960013798B1 (en) * | 1992-04-24 | 1996-10-10 | 재단법인 한국전자통신연구소 | Optic switch |
-
1994
- 1994-06-24 IL IL11011794A patent/IL110117A0/en unknown
-
1995
- 1995-06-22 AU AU29980/95A patent/AU2998095A/en not_active Abandoned
- 1995-06-22 WO PCT/US1995/008005 patent/WO1996000074A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1996000074A1 (en) | 1996-01-04 |
AU2998095A (en) | 1996-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL110117A0 (en) | Pharmaceutical compositions comprising vitamin-d analogs | |
ZA957247B (en) | Pharmaceutical compositions | |
IL104068A0 (en) | Pharmaceutical compositions for inhalation | |
HU9503199D0 (en) | Pharmaceutical basic compositions | |
ZA967827B (en) | Pharmaceutical compositions | |
IL119080A0 (en) | Pharmaceutical compositions containing tramadol | |
HUT74746A (en) | Pharmaceutical compositions containing p antagonist | |
IL113329A0 (en) | Benzamide-containing pharmaceutical compositions | |
GB9418609D0 (en) | Pharmaceutical compositions | |
EG24294A (en) | Pharmaceutical compositions | |
GB9506382D0 (en) | Pharmaceutical compositions | |
HU9500618D0 (en) | Oral pharmaceutical compositions | |
ZA96525B (en) | Novel pharmaceutical compositions | |
GB9513972D0 (en) | Pharmaceutical compositions | |
ZA954469B (en) | Pharmaceutical compositions | |
ZA959081B (en) | Pharmaceutical compositions | |
GB9406835D0 (en) | Pharmaceutical compositions | |
GB2295825B (en) | Pharmaceutical compositions | |
HU9601821D0 (en) | Pharmaceutical compositions | |
HU9400096D0 (en) | Pharmaceutical compositions | |
GB2285923B (en) | Pharmaceutical compositions containing N-acetal-cysteine | |
GB9707483D0 (en) | Pharmaceutical compositions | |
GB9405879D0 (en) | Pharmaceutical compositions | |
GB9413072D0 (en) | Pharmaceutical compositions | |
GB9406121D0 (en) | Pharmaceutical compositions |